INTERPACE BIOSCIENCES, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • January 17th, 2020 • Interpace Biosciences, Inc. • Surgical & medical instruments & apparatus • Delaware
This Indemnification Agreement (“Agreement”) is effective as of January __, 2020, by and between Interpace Biosciences, Inc., a Delaware corporation (the “Company” or “Interpace”), and [ ] (“Indemnitee”).
AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENTAddendum Agreement • January 17th, 2020 • Interpace Biosciences, Inc. • Surgical & medical instruments & apparatus • Delaware
THIS AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (this “Agreement”) is entered into as of January 15, 2020, by and among Interpace Biosciences, Inc., a Delaware corporation (the “Company”), 1315 Capital II, L.P., a Delaware limited partnership (including its successors and assigns, “1315 Capital”) and Ampersand 2018 Limited Partnership, a Delaware limited partnership (including its successors and assigns, “Ampersand” and, together with 1315 Capital, the “Investors” and each an “Investor”).
